GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles
Status:
Recruiting
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
Evaluation of the effect of adding a single dose of gonadotropin releasing hormone agonist
(GnRHa) as a luteal phase support on the outcomes of intracytoplasmic sperm injection (ICSI)
following GnRH antagonist protocol